USANA Health Sciences, Inc. (USNA) Director Myron W. Wentz Sells 40,000 Shares
USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 40,000 shares of the firm’s stock in a transaction on Tuesday, October 3rd. The shares were sold at an average price of $57.54, for a total transaction of $2,301,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
USANA Health Sciences, Inc. (USNA) traded up 0.78% on Thursday, hitting $58.30. 19,129 shares of the company were exchanged. The company has a 50 day moving average price of $57.78 and a 200-day moving average price of $60.12. The stock has a market capitalization of $1.43 billion, a P/E ratio of 15.14 and a beta of 1.09. USANA Health Sciences, Inc. has a 52 week low of $52.55 and a 52 week high of $75.00.
USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, July 25th. The company reported $0.98 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.06 by ($0.08). The firm had revenue of $257.10 million during the quarter, compared to the consensus estimate of $273.61 million. USANA Health Sciences had a return on equity of 28.93% and a net margin of 9.47%. The business’s revenue for the quarter was down .5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.07 EPS. On average, equities analysts expect that USANA Health Sciences, Inc. will post $3.79 earnings per share for the current fiscal year.
USANA Health Sciences declared that its board has initiated a stock buyback plan on Tuesday, July 25th that authorizes the company to buyback $64.60 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 46% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board believes its shares are undervalued.
TRADEMARK VIOLATION NOTICE: “USANA Health Sciences, Inc. (USNA) Director Myron W. Wentz Sells 40,000 Shares” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/10/05/usana-health-sciences-inc-usna-director-myron-w-wentz-sells-40000-shares.html.
USNA has been the topic of a number of recent research reports. BidaskClub raised shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research note on Tuesday, June 13th. Pivotal Research dropped their price objective on shares of USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating on the stock in a research note on Wednesday, July 26th.
A number of institutional investors and hedge funds have recently bought and sold shares of USNA. Russell Investments Group Ltd. lifted its stake in USANA Health Sciences by 11.8% during the 1st quarter. Russell Investments Group Ltd. now owns 27,619 shares of the company’s stock valued at $1,591,000 after acquiring an additional 2,926 shares during the period. Wells Fargo & Company MN lifted its stake in USANA Health Sciences by 70.8% during the 1st quarter. Wells Fargo & Company MN now owns 31,480 shares of the company’s stock valued at $1,814,000 after acquiring an additional 13,044 shares during the period. First Trust Advisors LP lifted its stake in USANA Health Sciences by 104.3% during the 1st quarter. First Trust Advisors LP now owns 25,069 shares of the company’s stock valued at $1,444,000 after acquiring an additional 12,800 shares during the period. Karp Capital Management Corp bought a new position in USANA Health Sciences during the 1st quarter valued at about $595,000. Finally, Ameriprise Financial Inc. lifted its stake in USANA Health Sciences by 19.6% during the 1st quarter. Ameriprise Financial Inc. now owns 44,563 shares of the company’s stock valued at $2,567,000 after acquiring an additional 7,305 shares during the period. Institutional investors and hedge funds own 44.87% of the company’s stock.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Stock Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related stocks with our FREE daily email newsletter.